Table 3.
Characteristic | NBL Profile (n = 50) |
BL Profile (n = 20) |
P | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Age, years | |||||
Median | 61 | 59.25 | |||
Range | 39-89 | 44-80 | .55 | ||
Grade | |||||
1-2 | 9 | 18 | 1 | 5 | .477 |
3 | 41 | 82 | 19 | 95 | |
Histology | |||||
Serous | 46 | 92 | 19 | 95 | .412 |
Clear cell | 1 | 2 | 1 | 5 | |
Endometrioid | 3 | 6 | 0 | 0 | |
Stage | |||||
2 | 3 | 6 | 0 | 0 | .479 |
3 | 41 | 82 | 16 | 80 | |
4 | 6 | 12 | 4 | 20 | |
Debulking status* | |||||
Optimal | 33 | 67.3 | 16 | 80 | .386 |
Suboptimal | 16 | 32.7 | 4 | 20 | |
Achievement of CR after first-line therapy | 37 | 74 | 18 | 90 | .2 |
Abbreviations: NBL, non–BRCA-like; BL, BRCA-like; CR, complete response.
Debulking status was unknown for one patient. Optimal was defined as less than or equal to 1 cm; suboptimal, greater than 1 cm.